QUICK ANSWER
On September 28, 2026, the FDA said it intends to evaluate changes to the premarket tobacco product application (PMTA) framework, possibly through a new rule that replaces the current one. Nothing changes yet: the FDA is still reviewing applications under the existing standard and has given no timeline. The move follows an August 2026 appeals court loss on flavored e-liquid denials and a September lawsuit by Altria over review delays.
What the FDA announced
The PMTA is the application every new vape, e-liquid and nicotine pouch needs before it can legally be sold in the US. On September 28, the FDA said it intends to evaluate changes to that framework, which could include new rulemaking “to replace the current framework.”
The agency pointed to its experience with the current rule, the growth of the illicit market, how quickly new products appear and recent litigation. It said a “modern framework that reflects current market realities” would bring more clarity. In the meantime, the FDA says it will keep reviewing applications and issuing decisions under the existing “appropriate for the protection of public health” standard, and that any changes will go through public comment.
The FDA reviews every new vape product through the PMTA process.
Why this is happening now
.1.Aug 19, 2026: a court loss on flavorsIn NicQuid v. FDA, the Fifth Circuit held that the comparative efficacy standard the FDA used to deny flavored e-liquid applications was a substantive rule that needed formal notice-and-comment rulemaking. The court vacated the denial and sent it back to the agency.
.2.Sept 2, 2026: Altria suesTwo Altria subsidiaries and the Texas Food and Fuel Association sued the FDA in federal court in Lubbock, Texas, arguing the agency has never met the 180-day statutory deadline for decisions. Altria says some of its applications have been pending for more than six years.
.3.Sept 23, 2026: reports of a rewriteReuters relayed a Wall Street Journal report that the FDA would revisit the 2021 rule, possibly simplifying study requirements and shortening reviews. The FDA has not confirmed those details.
.4.Sept 28, 2026: FDA confirms a reviewThe agency announces it will evaluate changes to the PMTA framework.
How the PMTA overhaul came about.
What could change, and what cannot
COULD CHANGE BY RULE
How reviews work
What studies an application needs
How long reviews take in practice
How the FDA weighs flavors and adult switching
SET BY CONGRESS
The law itself
Every new product still needs FDA authorization
The 180-day decision deadline
The “protection of public health” standard
A new rule has to go through a proposal, a public comment period and a final rule, which usually takes a year or more. Some parts of the system are written into the Tobacco Control Act and can only be changed by Congress.
PMTA filings can run to thousands of pages of studies and data.
What it means for adult vapers
Nothing changes right away. The FDA-authorized list is still short: as of August 2026, 48 e-cigarette products from Glas, JUUL, Logic, NJOY and Vuse.
More authorized products are possible later, potentially including flavors. In May 2026 the FDA authorized four Glas pods in non-tobacco, non-menthol flavors, paired with age-verification technology, which shows where the agency may be heading.
State laws still apply. Directory laws in states like Pennsylvania and Virginia, and California’s Unflavored Tobacco List, decide what can be sold locally regardless of federal changes.
Frequently asked questions
What is a PMTA?
A premarket tobacco product application is the submission a company must file, and the FDA must approve, before a new tobacco or nicotine product such as a vape can be legally sold in the US.
Is the FDA getting rid of the PMTA process?
No. The FDA said it intends to evaluate changes and may write a new rule to replace the current framework. The requirement to get FDA authorization comes from federal law and remains in place.
When will the new PMTA rule take effect?
There is no timeline. A new rule would need a proposal, a public comment period and a final rule.
Will flavored vapes be approved?
Possibly in the future. In May 2026 the FDA authorized four non-tobacco, non-menthol Glas pods paired with age-verification technology, its first authorization of that kind.
How many vapes are FDA-authorized?
As of the FDA’s August 2026 update, 48 e-cigarette products from Glas, JUUL, Logic, NJOY and R.J. Reynolds (Vuse).